How to mount a successful coup d'etat: Lessons from the Bible (II Kings 11, II Chronicles 23)

The process whereby queen Athaliah was deposed and replaced as monarch of Judah by the boy-king Joash in the seventh century bce warrants analysis as a typical 'coup d'etat'. The purpose of the present article is to interpret the relevant biblical narratives (II Kings II and 11 Chron. 23) in terms relevant to that political concept. Specifically, it posits that the organization and implementation of this highly successful coup can be illuminated by reference to modern political science literature on regime change. Thus read, the biblical records of the episode constitute a detailed 'how to' manual of political action.     

Band divided--the dispute surrounding the applications for the registration of 'Frankie Goes To Hollywood' as both UK and Community trade marks

Both the UKIPO and OHIM rule in favour of the opposition broughtby a group of reunited band members against an application bya sole former member to register the band's name as a trademark.     

The great tradition: The spread of diplomacy in the ancient world

Diplomacy as we understand it to the present day — a sophisticated system for handling affairs of state and negotiating treaties, based on accredited envoys working within a framework of international law and protocol - emerged in the third millennium BCE in the ancient Near East at the same time as the development of writing and urban culture. Transmitted by the great cuneiform civilizations of Babylon and Assyria to Achaemenid Persia and classical Greece and Rome, the heritage of diplomacy continued to flourish in Byzantium, Rome, and Venice. The Renaissance provided the conditions for the spread of a tradition that had existed in many essential aspects for millennia.     

COMPARING LOCAL GOVERNANCE: TRENDS AND DEVELOPMENTS

COMPARING LOCAL GOVERNANCE: TRENDS AND DEVELOPMENTS
Bas Denters and Lawrence E. Rose (eds)
Palgrave Macmillan, 2005, xiv + 293 pp., £18.99 (pb) ISBN: 0333995562     

Role of budget impact in drug reimbursement decisions

There are three known criteria that underlie drug reimbursement decisions: therapeutic value, cost-effectiveness, and burden of disease. However, evidence from recent reimbursement decisions in several jurisdictions points to residual, unexplained variables, among which is budget impact. Budget impact refers to the total costs that drug reimbursement and use entail with respect to one part of the health care system, pharmaceutical care, or to the entire health care system, taking into account the possible reallocation of resources across budgets or sectors of the health care system. The economic and equity rationale for carrying out budget impact analyses is opportunity cost, or benefits forgone, measured in terms of utility or equitable distribution, by using resources in one way rather than another. In other words, by choosing to draw down the budget in one way, decision makers forgo other opportunities to use the same resources. Under a set of unrealistic assumptions, cost-effectiveness analysis accounts for opportunity cost while conveying to the decision maker the price of maximizing health gains, subject to a budget or resource constraint. However, the underlying assumptions are implausible, particularly in the context of pharmaceutical care. Moreover, budget impact analysis is more useful to the decision maker than cost-effectiveness analysis if the objective is not to maximize health gains subject to a budget or resource constraint, but to reduce variance in health gains. With respect to equitable distribution, budget impact analyses lay bare the individuals or groups who lose out - those who bear the opportunity cost of spending resources in accordance with one decision rule rather than another.